Source:http://linkedlifedata.com/resource/pubmed/id/15319774
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2004-8-20
|
pubmed:abstractText |
A recent phase III trial comparing granulocyte colony-stimulating factor (G-CSF)-stimulated bone marrow (G-BM) and G-CSF-mobilized peripheral blood (G-PB) in matched sibling allograft recipients showed that G-BM produced a similar hematologic recovery but a reduced incidence of extensive chronic graft-versus-host disease, indicating differences in the cell populations infused. As a first step toward identifying these differences, we treated a group of healthy adult humans with 4 daily doses of G-CSF 10 microg/kg and monitored the effects on various hematopoietic and immune cell types in the PB and BM over 12 days. G-CSF treatment caused rapid and large but transient increases in the number of circulating CD34+ cells, colony-forming cells, and long-term culture-initiating cells and in the short-term repopulating activity detectable in nonobese diabetic/severe combined immunodeficiency/beta2-microglobulin-null mice. Similar but generally less marked changes occurred in the same cell populations in the BM. G-CSF also caused transient perturbations in some immune cell types in both PB and BM: these included a greater increase in the frequency of naive B cells and CD123+ dendritic cells in the BM. The rapidity of the effects of G-CSF on the early progenitor activity of the BM provides a rationale for the apparent equivalence in rates of hematologic recovery obtained with G-BM and G-PB allotransplants. Accompanying effects on immune cell populations are consistent with a greater ability of G-BM to promote tolerance in allogeneic recipients, and this could contribute to a lower rate of chronic graft-versus-host disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1083-8791
|
pubmed:author |
pubmed-author:CoubanStephenS,
pubmed-author:EavesConnie JCJ,
pubmed-author:GilmanAndrewA,
pubmed-author:ImrenSuzanS,
pubmed-author:IssekutzAndrewA,
pubmed-author:LuoZhijuanZ,
pubmed-author:PanzarellaTonyT,
pubmed-author:ReganJillJ,
pubmed-author:SadekIreneI,
pubmed-author:SchultzKirk RKR,
pubmed-author:ShierLuke RLR
|
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
624-34
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15319774-Adult,
pubmed-meshheading:15319774-Antigens, CD,
pubmed-meshheading:15319774-Antigens, CD34,
pubmed-meshheading:15319774-Bone Marrow Cells,
pubmed-meshheading:15319774-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:15319774-Hematopoietic Stem Cell Mobilization,
pubmed-meshheading:15319774-Hematopoietic Stem Cells,
pubmed-meshheading:15319774-Humans,
pubmed-meshheading:15319774-Lymphocytes,
pubmed-meshheading:15319774-Reference Values
|
pubmed:year |
2004
|
pubmed:articleTitle |
Differential effects of granulocyte colony-stimulating factor on marrow- and blood-derived hematopoietic and immune cell populations in healthy human donors.
|
pubmed:affiliation |
Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|